Treating silent killer cuts risk of stroke and death

June 20, 2014 by Dan Gaffney
A 12 lead ECG showing atrial fibrillation at approximately 150 beats per minute. Credit: James Heilman, MD/Wikipedia/CC BY-SA 3.0

(Medical Xpress)—Opportunistic detection of asymptomatic atrial fibrillation (AF) and treating it with anticoagulants can greatly reduce the risk of stroke and premature death, a new landmark study reveals.

AF is a common abnormal heart rhythm that poses the risk of blood clots forming inside the heart. When clots break off they usually travel to the brain, causing severe strokes.

Published in the latest issue of Thrombosis and Haemostasis, the study is the first to reveal the serious risk of , heart attack and death associated with incidentally detected AF.

It shows that finding previously undetected asymptomatic AF carries a doubling of the risk of stroke and a doubling of compared to age and gender matched control subjects.

More positively, the study reveals that treating asymptomatic AF with an oral anticoagulant drug (warfarin) almost completely reversed the increased risk of stroke, and partially reversed the increased risk of death.

It also shows that treating asymptomatic AF with aspirin did not significantly reduce either stroke or death, but still predisposed people to bleeding.

"This study indicates that widespread screening for asymptomatic atrial fibrillation could cost effectively reduce strokes and their associated disability, and help save lives," says study co-author, University of Sydney Cardiology Professor Ben Freedman.

AF is a common and serious accounting for 30 per cent of strokes. In 20 to 45 per cent of AF-related strokes this heart arrhythmia hadn't been detected prior to stroke as it is often asymptomatic.

Also, incidentally detected AF isn't usually associated with palpitations or elevated rate, which may explain why stroke can be an unexpected and serious first sign of AF.

In another recent study, Freedman and colleagues showed that AF could be detected easily and accurately with a simple, inexpensive ECG using a novel hand-held device attached to an iPhone. The iPhone-based ECG device can diagnose AF within 30 seconds.

"Given such easy ways to detect AF, and our demonstration of the poor outcomes that can be substantially modified by treatment, our results would make a reasonable case to screen for this in the population, as well as in the clinic," Professor Freedman says.

Fast Facts on , screening and treatment:

  • Atrial fibrillation (AF) is responsible for one third of all strokes.
  • 20 to 45 per cent of AF-related strokes aren't detected prior to stroke because AF is often asymptomatic (no apparent symptioms)
  • AF-related strokes are more severe and cause greater disability than non-AF strokes
  • Widespread screening for asymptomatic AF among people aged 65 years and over would be a potent way to prevent strokes and the burden of stroke-related harm because AF-related strokes are largely preventable by treatment with oral anticoagulant drugs.

Explore further: Researchers deliver novel stroke test in pharmacies

Related Stories

Researchers deliver novel stroke test in pharmacies

April 2, 2014
(Medical Xpress)—University of Sydney researchers have examined a unique way to identify the thousands of people at risk of stroke every year, using an ECG test delivered over an IPhone by pharmacists.

Aspirin still overprescribed for stroke prevention in atrial fibrillation

January 28, 2014
Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.

Women and African-Americans at higher risk of heart attack from atrial fibrillation

November 4, 2013
Doctors have known for years that atrial fibrillation (AF), or irregular heartbeat, increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart ...

Minorities face disparities in treatment and outcomes of atrial fibrillation

April 30, 2014
Atrial fibrillation (AF), a condition where the heartbeat speeds up or becomes irregular, is not usually life-threatening but can lead to complications such as stroke and heart failure. Even though minorities historically ...

The Medical Minute: Atrial Fibrillation -- What is It?

October 6, 2011
Atrial fibrillation (AF) is the most common heart rhythm disturbance in the United States and affects 2 to 4 million Americans. It is usually a disease of aging, however it can affect people of all ages -- 1 percent of people ...

Review of stroke treatment could save lives

September 30, 2011
Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.